PARAGON 28 INC

NYSE: FNA (Paragon 28, Inc.)

最近更新时间: 09 Oct, 2024, 8:20PM

5.25

-0.01 (-0.19%)

前收盘价格 5.26
收盘价格 5.22
成交量 478,472
平均成交量 (3个月) 561,121
市值 438,597,088
价格/销量 (P/S) 3.49
股市价格/股市净资产 (P/B) 6.16
52周波幅
5.09 (-3%) — 14.79 (181%)
利润日期 4 Nov 2024 - 8 Nov 2024
营业毛利率 -22.92%
营业利益率 (TTM) -13.56%
稀释每股收益 (EPS TTM) -0.670
季度收入增长率 (YOY) 18.10%
总债务/股东权益 (D/E MRQ) 80.05%
流动比率 (MRQ) 3.50
营业现金流 (OCF TTM) -40.24 M
杠杆自由现金流 (LFCF TTM) -29.19 M
资产报酬率 (ROA TTM) -8.39%
股东权益报酬率 (ROE TTM) -33.71%

市场趋势

短期 中期
行业 Medical Devices (US) 混合的 混合的
Medical Devices (全球的) 混合的 混合的
股票 Paragon 28, Inc. 看跌 看跌

AIStockmoo 评分

1.4
分析师共识 3.0
内部交易活动 NA
价格波动 0.5
技术平均移动指标 0.0
技术振荡指标 2.0
平均 1.38

相关股票

股票 市值 DY P/E(TTM) P/B
FNA 439 M - - 6.16
BIO 9 B - - 1.28
CNMD 2 B 0.80% 17.75 2.28
BSX 143 B - 79.93 6.75
SYK 139 B 0.89% 39.08 6.83
PHG 23 B - - 1.86

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

部门 Healthcare
行业 Medical Devices
投资方式 Small Core
内部持股比例 40.56%
机构持股比例 60.95%

所有权

姓名 日期 持有股份
Mvm Partners, Llc 30 Jun 2024 10,886,145
First Light Asset Management, Llc 30 Jun 2024 8,174,832
Braidwell Lp 30 Jun 2024 4,150,109
Bleichroeder Lp 30 Jun 2024 1,763,339
Degroof Petercam Asset Management 31 Mar 2024 974,000
52周波幅
5.09 (-3%) — 14.79 (181%)
目标价格波幅
13.00 (147%) — 15.00 (185%)
15.00 (Canaccord Genuity, 185.71%) 购买
14.00 (166.67%)
13.00 (Needham, 147.62%) 购买
平均值 14.00 (166.67%)
总计 2 购买
平均价格@调整类型 10.52
公司 日期 目标价格 调整类型 价格@调整类型
Needham 13 Jan 2025 13.00 (147.62%) 购买 10.74
13 Nov 2024 13.00 (147.62%) 购买 10.30
Canaccord Genuity 13 Nov 2024 15.00 (185.71%) 购买 10.30

该时间范围内无数据。

日期 类型 细节
13 Jan 2025 公告 Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024
03 Jan 2025 公告 Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
11 Dec 2024 公告 Paragon 28 Appoints Dave Demski to Board of Directors
18 Nov 2024 公告 Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference
12 Nov 2024 公告 Paragon 28 Reports Third Quarter 2024 Financial Results and Raises 2024 Net Revenue Guidance
08 Nov 2024 公告 SHAREHOLDER DEADLINE: Paragon 28 (FNA) Investors Are Reminded of Deadline in Securities Action
04 Nov 2024 公告 ATTENTION Paragon 28 (FNA) Shareholders: Securities Fraud Lawsuit Filed Against Paragon 28 (FNA)
28 Oct 2024 公告 Kaplan Fox Alerts Paragon 28 Investors to a Securities Class Action Lawsuit - Deadline is November 29, 2024
26 Oct 2024 公告 FNA DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Paragon 28, Inc. and Lead Plaintiff Deadline on November 29, 2024
25 Oct 2024 公告 FNA SHAREHOLDER ACTION ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Paragon 28, Inc. (FNA) and Lead Plaintiff Deadline on November 29, 2024
24 Oct 2024 公告 FNA CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Paragon 28, Inc. (FNA) and Lead Plaintiff Deadline on November 29, 2024
23 Oct 2024 公告 FNA DEADLINE FOR LEADERSHIP is November 29, 2024 in a Securities Fraud Lawsuit - Contact Kaplan Fox
17 Oct 2024 公告 Paragon 28 To Report Third Quarter 2024 Financial Results on November 12, 2024
16 Oct 2024 公告 Paragon 28 Launches the Phantom® Fibula Nail System for Less Invasive Fracture Repair
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票